These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 28235974

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of exogenous glucagon-like peptide-1 on the blood pressure, heart rate, mesenteric blood flow, and glycemic responses to intraduodenal glucose in healthy older subjects.
    Trahair LG, Horowitz M, Hausken T, Feinle-Bisset C, Rayner CK, Jones KL.
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2628-34. PubMed ID: 25210879
    [Abstract] [Full Text] [Related]

  • 3. Renal extraction and acute effects of glucagon-like peptide-1 on central and renal hemodynamics in healthy men.
    Asmar A, Simonsen L, Asmar M, Madsbad S, Holst JJ, Frandsen E, Moro C, Jonassen T, Bülow J.
    Am J Physiol Endocrinol Metab; 2015 Apr 15; 308(8):E641-9. PubMed ID: 25670826
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. GLP-1 Receptor Agonist Exenatide Increases Capillary Perfusion Independent of Nitric Oxide in Healthy Overweight Men.
    Smits MM, Muskiet MH, Tonneijck L, Kramer MH, Diamant M, van Raalte DH, Serné EH.
    Arterioscler Thromb Vasc Biol; 2015 Jun 15; 35(6):1538-43. PubMed ID: 25908765
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of small intestinal glucose load on blood pressure, splanchnic blood flow, glycemia, and GLP-1 release in healthy older subjects.
    Vanis L, Gentilcore D, Rayner CK, Wishart JM, Horowitz M, Feinle-Bisset C, Jones KL.
    Am J Physiol Regul Integr Comp Physiol; 2011 Jun 15; 300(6):R1524-31. PubMed ID: 21389332
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats.
    Wu L, Olverling A, Huang Z, Jansson L, Chao H, Gao X, Sjöholm Å.
    Clin Sci (Lond); 2012 Apr 15; 122(8):375-84. PubMed ID: 22054347
    [Abstract] [Full Text] [Related]

  • 15. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
    Kolligs F, Fehmann HC, Göke R, Göke B.
    Diabetes; 1995 Jan 15; 44(1):16-9. PubMed ID: 7813808
    [Abstract] [Full Text] [Related]

  • 16. GLP-2 and mesenteric blood flow.
    Hansen LB.
    Dan Med J; 2013 May 15; 60(5):B4634. PubMed ID: 23673268
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Glucagon-Like Peptide-1 Analog Exenatide Increases Blood Glucose Clearance, Lactate Clearance, and Heart Rate in Comatose Patients After Out-of-Hospital Cardiac Arrest.
    Wiberg S, Kjaergaard J, Schmidt H, Thomsen JH, Frydland M, Winther-Jensen M, Lindholm MG, Høfsten DE, Engstrøm T, Køber L, Møller JE, Hassager C.
    Crit Care Med; 2018 Feb 15; 46(2):e118-e125. PubMed ID: 29189347
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.